Singapore Medical Group Ltd
SGX:5OT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sinofibers Technology Co Ltd
SZSE:300777
|
CN |
|
A
|
ASX Ltd
OTC:ASXFY
|
AU |
|
Ichimasa Kamaboko Co Ltd
TSE:2904
|
JP |
|
VICI Properties Inc
NYSE:VICI
|
US |
|
Ducommun Inc
NYSE:DCO
|
US |
EV/EBIT
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBIT returns to its 3-Year Average (10.8), the stock would be worth S$0.4 (0% downside from current price).
| Scenario | EV/EBIT Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 10.8 | S$0.4 |
0%
|
| 3-Year Average | 10.8 | S$0.4 |
0%
|
| 5-Year Average | 10.8 | S$0.4 |
0%
|
| Industry Average | 20.3 | S$0.74 |
+88%
|
| Country Average | 14.1 | S$0.52 |
+31%
|
Forward EV/EBIT
Today’s price vs future ebit
| Today's Enterprise Value | EBIT | Forward EV/EBIT | ||
|---|---|---|---|---|
|
S$172.2m
|
/ |
Jul 2022
S$16m
|
= |
|
|
S$172.2m
|
/ |
Dec 2022
S$17.5m
|
= |
|
|
S$172.2m
|
/ |
Dec 2023
S$18.9m
|
= |
|
Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.
Peer Comparison
| Market Cap | EV/EBIT | P/E | ||||
|---|---|---|---|---|---|---|
| SG |
|
Singapore Medical Group Ltd
SGX:5OT
|
192.2m SGD | 10.8 | 13.1 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
97.1B USD | 14 | 54.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
69.3B EUR | 9.9 | 13.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
72.4B USD | 0 | 12.1 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
23.9B EUR | 14.2 | 18.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23B EUR | 16.8 | 23.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.4B USD | 16.5 | 22.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.4B USD | 17.7 | 25.5 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR | 9.9 | 11.2 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.7B USD | -27.9 | -28.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.4B USD | 9.8 | 14 |
Market Distribution
| Min | 0 |
| 30th Percentile | 8.1 |
| Median | 14.1 |
| 70th Percentile | 23.5 |
| Max | 6 029.3 |
Other Multiples
Singapore Medical Group Ltd
Glance View
Singapore Medical Group Ltd. is an investment holding company, which engages in the management of medical clinics; and provision of general medical services. The company employs 296 full-time employees The company went IPO on 2009-07-23. The Company’s Health, Diagnostic & Aesthetics and Others. The Health segment comprises obstetrical and gynecological services; oncology services, including the prevention, diagnosis and treatment of cancer, cancer screening and cancer genetic and risk assessment; pediatrics services; general medicine and health screening services; cardiology services, and endocrinology services. The Diagnostic & Aesthetics segment comprises radiology and diagnostic imaging services; refractive surgery services; dental services including general dental services, prosthodontics, orthodontics, implant dentistry, oral surgery and gum treatment and aesthetics medicine services that offer healthcare services related to physical appearances. The Others segment comprises group-level corporate services as well as business consultancy functions and telemedicine services.
